PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Medical Microbiology Department, Federal State Budget Institution \'National Research Center for Epidemiology and Microbiology Named after Honorary Academician N.F. Gamaleya\' of the Ministry of Health of the Russian Federation, Moscow, Russia.\', \'Department of Genetics and Molecular Biology of Bacteria, Federal State Budget Institution \'National Research Centre for Epidemiology and Microbiology Named after Honorary Academician N.F. Gamaleya\' of the Ministry of Health of the Russian Federation, Moscow, Russia.\', \'Department of the National Virus Collection, Federal State Budget Institution \'National Research Centre for Epidemiology and Microbiology Named after Honorary Academician N.F. Gamaleya\' of the Ministry of Health of the Russian Federation, Moscow, Russia.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.3389/fimmu.2022.822159
?:hasPublicationType
?:journal
  • Frontiers in immunology
is ?:pmid of
?:pmid
?:pmid
  • 35281053
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.803
?:rankingScore_hIndex
  • 69
?:title
  • Single-Domain Antibodies Efficiently Neutralize SARS-CoV-2 Variants of Concern.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all